facebook twitter rss 모바일웹

[의학신문·일간보사=오인규 기자] Genoray, a professional global radiology medical device company, continues to maintain its top position in the Korean market with its C-ARM and mammography (breast cancer detection screening device) developed based on its X-ray source core technology as the nation's first developer and its own manufacturing capacity.

Genoray, which is enjoying heightened reputation overseas, exporting its products to some 80 countries including the U.S. and Russia, will present its best-selling surgical C-ARM and flagship mammography along with 3D x-ray diagnosis device for otolaryngology (ENT 3D CBCT) at this year's International Medical Equipment and Hospital Equipment Exhibition (KIMES).

The company also plans to launch its new mammography device, "HESTIA," which is Korea's first-ever brand to be equipped with the DBT (Digital Breast Tomosynthesis) function.

A staff of Genoray says, "for the past 2 decades, Genoray has been localizing core technology to secure a high level of technological dependence, thereby making preparations to become a 'top global X-ray brand,'" adding that "marking the 20th anniversary of its founding, Genoray will be further developing itself amid competition with global companies based on its advanced technological capabilities and quality and with a new resolve as a 20-year-old adult who is taking initial steps into the society."

■ Korea's First Manufacturer to Launch DBT Mammography ... Successfully Localizes Manufacturing of Equipment

“Integration of Core Technological Capabilities," ‘HESTIA’

"HESTIA," newly unveiled by Genoray, is equipped with DBT (Digital Breast Tomosynthesis) technology that enables the monitoring of breast tomography images unlike the existing 2D devices, enabling more precise diagnosis of breast cancer. It also raises breast cancer diagnosis efficiency by over 30%, and is a device that is optimized for the diagnosis of microcalcification or tumor in dense breasts, which are common among Korean and other Asian women.

Through its Image Chain technology, the company has accumulated for a long time, and optimization of professional imaging processing, and even in 2D specifications, the product minimizes radiation exposure to patients, delivers high quality images with high contrast as well as high resolution images and its DBT option provides breast tomography imaging that enables the exact identification of the type and location of breast tissues to allow precise diagnosis of cancer cells and microcalcification.

Added to this, the LED lamp on the side of the product enables users to check the operation status, while the audio guide and indicator functions have added to raising user convenience and patient stability.

"HESTIA" has also been named by Korea's most prestigious "2020 Good Design" for its exterior design that has adopted the women-friendly curved designs.

Moreover, it has also been noted for its design that considers space efficiency by adopting an all-in-one stand type design that has contributed to minimizing installation space.

Executive Manager Noh Gu-young in charge of Genoray Medical PDM (product development /planning supervising manager) says, "Korea has long been dependent on costly devices manufactured abroad as there has been no device manufactured within the country that delivers DBT function," adding that "HESTIA launched by Genoray will not only be used for professional diagnosis sectors like breast clinics and radiology departments, but also by medical examination centers at hospitals and health clinics that have long pondered upon the introduction of such device due to its high cost and maintenance expenses, by providing them with increased medical services for women by expanding the supply of DBT mammography."

■ 5th Largest Global C-ARM Market, Receiving Praise by U.S. State Hospitals... Verifying Its Competitiveness

High Performance and High Resolution ‘Flat Panel Detector’ C-ARM ‘OSCAR 15’

"OSCAR 15" is a mobile X-ray fluoroscopy screening device that is optimized for surgical environment. Ever since its launch, its competitiveness has been proven in the global C-ARM market. Equipped with the Rotating Anode Tube with 15kW-level Xray generator and 26cm x 26cm CMOS Flat Panel detector, it help users to acquire high quality resolution images even with low dosage.

Its de-noising function makes it possible to deliver optimized imaging quality, while its numerous Pulsed X-ray modes significantly decreases the risks of radiation among patients and users by minimizing the amount of radiation exposure.

Utilizing Genoray's Image Chain technology, which is an integrated form of the company's innovative technology and numerous years of know-how, the product provides optimized high quality medical imaging with minimum radiation exposure with numerous tailored functions - clinical application, surgical, patient, area and mode.

Director Oh Han-chang of Genoray's U.S. branch says, "OSCAR 15 is being highly praised for its high cost-effectiveness and outstanding imaging quality by many mid-and-large-sized hospitals within U.S. which has the world's largest X-ray medical device market," adding that "as a result, Genoray is being acknowledged for the quality and value of its C-ARM products, and thus it has achieved the success of supplying them to U.S. state hospitals."

Moreover, the product competitiveness of "OSCAR 15" has once again be proven for its high quality images compared to similar imported equipment through clinical trials conducted by Seoul National University Hospital, and will further be sold to mid-to-large-sized hospitals and other advanced countries.

■ "OSCAR 15" with Sufficient Competitiveness in Korean Vascular Surgical Device Market

Boasting compact design and outstanding performance, "OSCAR 15" is being used across many departments - orthoedics, neurosurgery, anesthesiology and pain medicine, rehabilitation treatment, urology and veterinary clinics. Acknowledged for its specialized vasography function, it is also being used within the vascular surgical market that is growing lately.

DSA (Digital Subtraction Angiography) function of "OSCAR 15" is effective in clinical diagnosis and surgical treatment thanks to the vessels image data acquired after injecting contrast medium to the patient, and thus many within the Korean vascular surgical market are choosing to adopt C-ARM capable of blood vessel imaging.

Providing 100um pixel high quality resolution images of blood vessels, "OSCAR 15" is being met with high level of customer satisfaction. It is also expected to be popular by leading the domestic vascular surgery market going forward as it not only provides various useful functions like high level of space efficiency with company design but also significantly reduces burden on expenses related to adoption and maintenance.

[Meet the on-line version of Medical Newspaper special edition articles that are distributed physically at KIMES 2021]